# Phase 2 colitis trials recruiting: 51 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 51 trials in phase 2 for colitis that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 colitis trials: 51 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/colitis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 51
- Recruiting or not yet: 51
- Read on: November 19, 2026

## Trials

The 25 newest of 51, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 13, 2026 | NCT07871669 | Efficacy and Safety of TRA16 Administered Orally in Patients With Enteric Hyperoxaluria (EH). | Wuhan Kangfude Urolithiasis Research Institute Co., Ltd. | Phase 2 | Not yet recruiting | Enteric Hyperoxaluria | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871669) |
| September 29, 2026 | NCT07845487 | A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis | Sponsor not shown (see the record) | Phase 2 | Recruiting | Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis | 204 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845487) |
| September 11, 2026 | NCT07814456 | Fecal Microbiota Transplantation for Ulcerative Colitis Using Dai and Han Donors | First Affiliated Hospital of Kunming Medical University | Phase 2 | Recruiting | Ulcerative Colitis (UC), Inflammatory Bowel Disease | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07814456) |
| August 10, 2026 | NCT07755241 | A Study of AC-101 Tablets in Patients With Ulcerative Colitis | Accro Bioscience (Suzhou) Limited | Phase 2 | Recruiting | Ulcerative Colitis (UC) | 153 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07755241) |
| August 5, 2026 | NCT07747155 | A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PTT-621 in Patients With Moderately to Severely Active... | Pyrotech Therapeutics, Inc. | Phase 2 | Not yet recruiting | Ulcerative Colitis (UC) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07747155) |
| July 13, 2026 | NCT07697456 | Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis | AbbVie | Phase 2 | Recruiting | Crohn's Disease, Ulcerative Colitis | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07697456) |
| June 12, 2026 | NCT07646223 | Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis | Tampere University Hospital | Phase 2 | Not yet recruiting | Ulcerative Colitis (UC), Primary Sclerosing Cholangitis (PSC), Pediatric Inflammatory Bowel Diseases | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07646223) |
| June 2, 2026 | NCT07619898 | PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to... | Therakos LLC | Phase 2 | Not yet recruiting | Colitis, Hepatitis, Melanoma (Skin Cancer) | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07619898) |
| April 6, 2026 | NCT07513181 | Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely... | Athos Therapeutics Inc | Phase 2 | Recruiting | Ulcerative Colitis, Inflammatory Bowel Diseases, Autoimmune Diseases | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07513181) |
| April 2, 2026 | NCT07507513 | The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Phase 2 | Recruiting | Ulcerative Colitis (UC) | 288 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07507513) |
| March 30, 2026 | NCT07501078 | Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation | Sponsor not shown (see the record) | Phase 2 | Recruiting | Ulcerative Colitis, Ileal Pouch | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07501078) |
| March 19, 2026 | NCT07483073 | A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease | Eli Lilly and Company | Phase 2 | Recruiting | Colitis, Ulcerative, Crohn Disease | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07483073) |
| March 13, 2026 | NCT07470879 | A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis | Pfizer | Phase 2 | Recruiting | Colitis, Ulcerative | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07470879) |
| March 11, 2026 | NCT07463183 | A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002) | Merck Sharp & Dohme LLC | Phase 2 | Recruiting | Colitis Ulcerative, Ulcerative Colitis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07463183) |
| February 23, 2026 | NCT07427017 | Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies | Northwestern University | Phase 2 | Recruiting | Ulcerative Colitis (UC) | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07427017) |
| February 17, 2026 | NCT07415044 | LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis | Eli Lilly and Company | Phase 2 | Recruiting | Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe | 1,431 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07415044) |
| January 14, 2026 | NCT07341282 | Investigation of Vancomycin Efficacy in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis | McMaster University | Phase 2 | Recruiting | Ulcerative Colitis (UC), Primary Sclerosing Cholangitis (PSC) | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07341282) |
| January 12, 2026 | NCT07335055 | A Study for HSK47388 in Participants With Ulcerative Colitis | Haisco Pharmaceutical Group Co., Ltd. | Phase 2 | Recruiting | Ulcerative Colitis (UC) | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07335055) |
| January 12, 2026 | NCT07333716 | Desloratadine in Patients With Ulcerative Colitis | Tanta University | Phase 2 | Recruiting | Ulcerative Colitis (UC), Ulcerative Colitis | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07333716) |
| December 24, 2025 | NCT07300553 | Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease | Assistance Publique - Hôpitaux de Paris | Phase 2 | Recruiting | IBD, Crohn Disease, Ulcerative Colitis (UC) | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07300553) |
| December 22, 2025 | NCT07296315 | Confirmatory Clinical Study in Active Ulcerative Colitis | MRM Health NV | Phase 2 | Recruiting | Colitis, Ulcerative | 204 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07296315) |
| December 22, 2025 | NCT07295834 | Modafinil For Fatigue in IBD: A Feasibility Randomised Controlled Trial | Imperial College London | Phase 2 | Not yet recruiting | Crohn Disease (CD), Ulcerative Colitis (UC), Fatigue | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07295834) |
| December 5, 2025 | NCT07265570 | Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA) | InSilico Medicine Hong Kong Limited | Phase 2 | Recruiting | Ulcerative Colitis | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07265570) |
| October 31, 2025 | NCT07223424 | Patient Preference for Subcutaneous vs. Intravenous Immune Therapy | Sponsor not shown (see the record) | Phase 2 | Recruiting | Renal Cell Carcinoma, Non Small Cell Lung Cancer, Melanoma, Colo-rectal Cancer (dMMR/MSI-H CRC), Hepatocellular... | 880 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07223424) |
| September 22, 2025 | NCT07186101 | LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis: | Eli Lilly and Company | Phase 2 | Recruiting | Ulcerative Colitis | 252 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07186101) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 3 |
| Tanta University | 2 |
| Alexandria University | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Brigham and Women's Hospital | 2 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 2 |
| Spyre Therapeutics, Inc. | 1 |
| First Affiliated Hospital of Kunming Medical University | 1 |
| Children's Hospital Los Angeles | 1 |
| [Biocad](https://specstream.ai/data/clinical-trials/company/biocad) | 1 |
| McMaster University | 1 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 1 |
| Imperial College London | 1 |
| Therakos LLC | 1 |
| Tampere University Hospital | 1 |
| Accro Bioscience (Suzhou) Limited | 1 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 1 |
| [Genentech, Inc.](https://specstream.ai/data/clinical-trials/company/genentech-inc) | 1 |
| Mirador Therapeutics, Inc. | 1 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 1 |
| The Second Hospital of Nanjing Medical University | 1 |
| Odense University Hospital | 1 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 1 |
| Northwestern University | 1 |
| Guangzhou Zhiyi Biotechnology Co., Ltd. | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 26 |
| Poland | 14 |
| Canada | 13 |
| China | 13 |
| Czechia | 8 |
| France | 8 |
| Italy | 8 |
| Japan | 7 |
| Germany | 6 |
| Hungary | 6 |
| Slovakia | 6 |
| Brazil | 5 |
| Israel | 5 |
| Serbia | 5 |
| South Korea | 5 |
| Ukraine | 5 |
| Australia | 4 |
| Georgia | 4 |
| India | 4 |
| Mexico | 4 |
| Moldova | 4 |
| Egypt | 4 |
| United Kingdom | 4 |
| Austria | 3 |
| Belgium | 3 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [French restaurants in the United States](https://specstream.ai/data/businesses/french-restaurants/united-states)
- [Ceiling and roofing repair and companies in the United States](https://specstream.ai/data/businesses/ceiling-and-roofing-repair-and-companies/united-states)
- [Welding supply stores in the United States](https://specstream.ai/data/businesses/welding-supply-stores/united-states)
- [Public health clinics in the United States](https://specstream.ai/data/businesses/public-health-clinics/united-states)
- [Landscape architecture firms in the United States](https://specstream.ai/data/businesses/landscape-architecture-firms/united-states)
- [Endocrinology practices in the United States](https://specstream.ai/data/businesses/endocrinology-practices/united-states)
